Recent findings from a multi-state study reveal that the RSV vaccine is approximately 80% effective in preventing severe ...

The Centers for Disease Control and Prevention and the New Orleans Health Department encourage residents to vaccine against ...

Respiratory syncytial virus, or RSV, typically presents as mild, with symptoms similar to the common cold for adults and ...

The CDC’s vaccine advisors on Thursday maintained that respiratory syncytial virus immunization is only recommended for ...

Starting Nov. 4, babies born in 2024 can get Beyfortus — also known as nirsevimab — to protect against severe illness from ...

The RSV vaccine is unequivocally recommended for adults who are residents in skilled nursing and assisted living facilities.

Sanofi and partner AstraZeneca recently increased production capacity for their RSV antibody shot, sales of which jumped ...

Experts share the official predictions for RSV surge levels in 2024 and 2025, why the levels change each year, and how to ...

New data for Arexvy, GSK’s RSV vaccine, show potential to help protect a broader group of adults at increased risk for RSV disease: London, UK Friday, October 25, 2024, 13:00 Hr ...

Expecting mothers in their 32nd to 36th week of pregnancy can get an RSV vaccine, which will pass along antibodies to their newborn. Or, babies up to eight months old, can get a monoclonal antibody ...

Health officials on Friday issued a fresh plea for Londoners to get vaccinated ahead of an expected surge of flu, Covid and ...

Health officials in Alberta are sounding an alarm over delays in delivery of some vaccines they say could be contributing to ...